Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Saudi J Kidney Dis Transpl ; 33(6): 839-843, 2022 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-38018725

RESUMO

Anabolic-androgenic steroids (AAS) have been widely used by young people to enhance performance and increase muscle mass. The use of AAS can affect the kidneys and lead to a myriad of presentations, ranging from mildly elevated serum creatinine and blood urea nitrogen to irreversible chronic kidney disease and focal segmental glomerulosclerosis (FSGS). To the best of our knowledge, the coexistence of interstitial nephritis and the cellular variant of FSGS [Immunoglobulin M (IgM)] secondary to AAS abuse has not been previously reported in the literature. Here, we report the case of a 40-year-old bodybuilder who developed simultaneous interstitial nephritis and the cellular variant of FSGS (IgM) after short-term use of AAS and other dietary supplements.


Assuntos
Glomerulosclerose Segmentar e Focal , Nefrite Intersticial , Humanos , Adolescente , Adulto , Glomerulosclerose Segmentar e Focal/induzido quimicamente , Glomerulosclerose Segmentar e Focal/diagnóstico , Glomerulosclerose Segmentar e Focal/complicações , Esteróides Androgênicos Anabolizantes , Rim , Congêneres da Testosterona/efeitos adversos , Nefrite Intersticial/induzido quimicamente , Nefrite Intersticial/diagnóstico , Nefrite Intersticial/complicações , Imunoglobulina M
2.
Saudi J Kidney Dis Transpl ; 28(4): 912-915, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28748897

RESUMO

Milk-Alkali syndrome (MAS) consists of a triad of hypercalcemia, metabolic alkalosis, and acute renal failure. We hereby report a 75-year-old Indian gentleman who presented to our emergency department with a history of generalized weakness and easy fatigability. Investigations were consistent with MAS secondary to calcium carbonate and calcitriol treatment to prevent osteoporosis, aggravated by H1N1 influenza vaccine. The patient was treated with hemodialysis and zoledronate. To our knowledge, this is the first reported case of such association in the literature.


Assuntos
Cálcio/sangue , Hipercalcemia/induzido quimicamente , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/administração & dosagem , Idoso , Biomarcadores/sangue , Conservadores da Densidade Óssea/efeitos adversos , Calcitriol/efeitos adversos , Carbonato de Cálcio/efeitos adversos , Humanos , Hipercalcemia/sangue , Hipercalcemia/diagnóstico , Hipercalcemia/terapia , Vacinas contra Influenza/imunologia , Masculino , Diálise Renal , Fatores de Risco , Resultado do Tratamento , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...